Nirav Dhanesha and LSU Health Shreveport Team Discover Neutrophil Integrin α9 as a Key Target in Subarachnoid Hemorrhage Recovery
Nirav Dhanesha, Assistant Professor at the Louisiana State University, shared an important post on LinkedIn:
“Excited to share our latest research on subarachnoid hemorrhage SAH! Our study in Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) reveals a novel role for neutrophil integrin α9 ITGA9 in sensorimotor and cognitive recovery after SAH.
We found that targeting ITGA9, which is expressed on neutrophils, significantly reduces inflammation and neuronal apoptosis. This leads to improved long-term outcomes after SAH.
Huge congratulations to the first author, Harpreet Kaur, Ph.D. for her outstanding work and dedication to this project! Her dedication was instrumental in the success of this study.
Special thanks to all the co-authors Arif Yurdagul Oren Rom, PhD, RD Wayne Orr Mohammad Alfrad Nobel Bhuiyan, PhD Rajesh Mohandas Ajit Vikram Kevin Murnane Xiao-Hong Lu for their invaluable support and collaborative spirit. This was a true team effort! LSU Health Shreveport”
Read the article here:
Article: Neutrophil Integrin α9 Impairs Efferocytosis and Worsens Long-Term Recovery After Subarachnoid Hemorrhage
Authors: Harpreet Kaur, Nilesh Pandey, Lakshmi Chandaluri, Nirvana Shaaban, Dhananjay Kumar, Rajan Pandit, Alexa Martinez, Sumit Kumar Anand, Sandeep Das, Sumati Rohilla, Fabio Arias, Erika Reece, Ravinder Reddy Gaddam, Kevin S. Murnane, Ajit Vikram, Rajesh Mohandas, Xiaolu Zhang, Mohammad Alfrad Nobel Bhuiyan, Xiao-Hong Lu, A. Wayne Orr, Oren Rom, Arif Yurdagul Jr, Nirav Dhanesha
Follow the latest insights in hematology with Hemostasis Today.
-
Sep 10, 2026, 16:12Balancing Thrombosis and Bleeding in Antiphospholipid Syndrome
-
Sep 10, 2026, 16:07Miguel Teran: Why ROTEM Will Redefine Major Bleeding Management
-
Sep 10, 2026, 16:04Isaac Okello: Where Skyline Meets Savannah – Quiet Moments at GASCDO in Nairobi
-
Sep 10, 2026, 15:58Joyisa Deb: How Immune Recognition Reshapes Clinical Practice
-
Sep 10, 2026, 15:56Alexsander Santiago: When Was Your ECMO Anticoagulation Target Last Challenged?
-
Sep 10, 2026, 15:51Christopher Bocquet: A Call for Feedback on the Proposed 13th Edition of Standards for Biotherapy Services
-
Sep 10, 2026, 15:45Amos Gitonga Mbaabu: GASCDO Conference in Nairobi – Translating Sickle Cell Innovations into Equitable Care
-
Sep 10, 2026, 15:36Majdouline El Moussaoui: What If AA Amyloidosis is the First Clue to an Undiagnosed Monogenic Autoinflammatory Disease?
-
Sep 10, 2026, 15:21Pathogenesis and Emerging Targeted Therapies in Myeloproliferative Neoplasms – NEJM Group